Empire Life Investments Inc. - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 193 filers reported holding NEKTAR THERAPEUTICS in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
Empire Life Investments Inc. ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q4 2022$228
-99.9%
100,945
-1.2%
0.02%
-36.0%
Q3 2022$327,000
-12.8%
102,178
+3.6%
0.02%
-7.4%
Q2 2022$375,000
-28.0%
98,609
+1.9%
0.03%
-18.2%
Q1 2022$521,000
-59.9%
96,742
+0.5%
0.03%
-58.2%
Q4 2021$1,300,000
-24.6%
96,245
+0.2%
0.08%
-30.1%
Q3 2021$1,725,000
+5.1%
96,022
+0.4%
0.11%
+6.6%
Q2 2021$1,642,000
-12.8%
95,677
+1.6%
0.11%
-17.8%
Q1 2021$1,883,000
+15.2%
94,163
-2.1%
0.13%
+11.2%
Q4 2020$1,635,000
+1.9%
96,167
-0.5%
0.12%
-10.1%
Q3 2020$1,604,000
-28.1%
96,666
+0.3%
0.13%
-34.2%
Q2 2020$2,232,000
+21.7%
96,362
-6.2%
0.20%
+16.7%
Q1 2020$1,834,000
-16.0%
102,757
+1.6%
0.17%
+1.2%
Q4 2019$2,184,000
+19.1%
101,163
+0.5%
0.17%
+7.8%
Q3 2019$1,833,000
-45.6%
100,656
+6.2%
0.15%
-43.4%
Q2 2019$3,372,000
+7.4%
94,789
+1.5%
0.27%
+3.4%
Q1 2019$3,139,000
+70.3%
93,434
+66.7%
0.26%
+58.4%
Q4 2018$1,843,000
-45.3%
56,057
+1.4%
0.17%
-35.4%
Q3 2018$3,370,000
+24.0%
55,281
-0.7%
0.26%
+31.1%
Q2 2018$2,717,00055,6450.20%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q1 2023
NameSharesValueWeighting ↓
Rhenman & Partners Asset Management AB 508,000$6,132,0001.80%
Bodri Capital Management, LLC 250,000$3,018,0001.46%
Granahan Investment Management 3,442,980$41,557,0001.28%
TIRSCHWELL & LOEWY INC 603,441$7,284,0001.22%
NEA Management Company, LLC 1,825,600$22,035,0001.12%
Cormorant Asset Management, LP 450,000$5,432,0001.12%
HARVEY CAPITAL MANAGEMENT INC 221,750$2,676,0001.05%
Cheyne Capital Management (UK) LLP 229,577$2,772,0000.99%
Artal Group S.A. 1,650,000$19,916,0000.73%
FIC CAPITAL INC 147,293$1,778,0000.71%
View complete list of NEKTAR THERAPEUTICS shareholders